Clinical Practice Guidelines - National Health and Medical Research ...

29. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable
rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980–7.
30. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on
preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based
study. Cancer 2001; 92: 896–902.
31. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative
radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for
rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396–402.
32. Glehen O, Chapet O, Adham M, Nemoz JC, Gerard JP. Long-term results of the Lyons R90-
01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on
sphincter-saving surgery in rectal cancer. Br J Surg 2003; 90: 996–8.
33. Marijnen CA, Nagtegaal ID, Klein KE, et al. No downstaging after short-term preoperative
radiotherapy in rectal cancer patients. J Clin Oncol 2001; 19: 1976–84.
34. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in
adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation
of late secondary effects. Dis Colon Rectum 1993; 36: 564–72.
35. Barton M. Tables of equivalent dose in 2 Gy fractions: a simple application of the linear
quadratic formula. Int J Radiat Oncol Biol Phys 1995; 31: 371–8.
36. Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y. Adjuvant therapy with oral
fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal
cancer: individual patient data meta-analysis of randomized trials. Jpn J Clin Oncol 1999; 29:
78–86.
37. Zoetmulder F, Taal B, van Tinteren H. Adjuvant 5FU plus levamisole improves survival in
stage II and III Colonic cancer, but not in rectal cancer. Interim analysis of the Netherlands
Adjuvant Colorectal Cancer Project (NACCP). Proc Am Soc Clin Onco 1999; 18.
38. Ooi BS, Tjandra JJ, Green MD. Morbidities of adjuvant chemotherapy and radiotherapy for
resectable rectal cancer: an overview. Dis Colon Rectum 1999; 42: 403–18.
39. Gelber RD, Goldhirsch A, Cole BF, Wieand HS, Schroeder G, Krook JE. A quality-adjusted
time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and
chemotherapy for resectable rectal cancer. J Natl Cancer Inst 1996; 88: 1039–45.
40. Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after
short-term preoperative radiotherapy combined with total mesorectal excision in primary
rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002; 20: 817–25.
41. Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Side effects after preoperative radiotherapy
followed by TME surgery. Proc Euro Soc Ther Radio Oncol 2002; 21.
42. Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects functional
results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum
1998; 41: 543–9.
43. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM. The
long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel
function. Ann Surg 1994; 220: 676–82.
196
The prevention, early detection and management of colorectal cancer